z-logo
open-access-imgOpen Access
Can Plateletcrit be a Marker for Recurrent Pregnancy Loss?
Author(s) -
Öner Aynıoğlu,
Hatice Işık,
Ahmet Şahbaz,
Mehmet Harma,
Metin IŞIK,
Fürüzan Köktürk
Publication year - 2014
Publication title -
clinical and applied thrombosis/hemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 53
eISSN - 1938-2723
pISSN - 1076-0296
DOI - 10.1177/1076029614565882
Subject(s) - mean platelet volume , medicine , methylenetetrahydrofolate reductase , white blood cell , red blood cell distribution width , thrombophilia , gastroenterology , preeclampsia , complete blood count , pregnancy , gynecology , platelet , immunology , biology , thrombosis , genotype , genetics , gene
Aim: To determine the utility of platelet (PLT) indices for the prediction of recurrent pregnancy loss (RPL).Methods: In all, 208 patients who experienced 2 or more first trimester spontaneous abortions and 95 controls who had no abortions were studied. The hematological markers, including plateletcrit (PCT) and neutrophil (Neu) to lymphocyte (Lym) ratio (NLR), were measured. Thrombophilia genetic tests for factor V Leiden mutation, prothrombin G202I0A mutation, and methylenetetrahydrofolate reductase C677 T and A1298C mutations were performed.Results: The PLT count, PCT, white blood cell count, red cell distribution width (RDW), Lym and Neu count, and NLR were significantly higher in patients with RPL than in controls. The RDW, PLT, and PCT values were higher in the low-risk group, whereas mean PLT volume values were lower than the high-risk group values.Conclusion: Plateletcrit is a low-cost, widely available marker for prediction of RPL in patients with a history of at least 1 abortus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom